Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
02/07/2002 | WO2002010762A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
02/07/2002 | WO2002010758A2 Surface-attached polyfunctional polymer networks for sensor chips |
02/07/2002 | WO2002010750A2 Biosensors, reagents and diagnostic applications of directed evolution |
02/07/2002 | WO2002010749A1 Method of screening substance for preventing or treating diseases in association with il-6 family cytokine receptor malfunction |
02/07/2002 | WO2002010745A2 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
02/07/2002 | WO2002010736A1 Method for analysing nucleic acids |
02/07/2002 | WO2002010458A2 Method of performing subtractive hybridization |
02/07/2002 | WO2002010454A2 Haplotypes of the alas2 gene |
02/07/2002 | WO2002010453A2 Molecular toxicology modeling |
02/07/2002 | WO2002010451A1 Transgenic identification markers |
02/07/2002 | WO2002010450A2 Replicable probe array |
02/07/2002 | WO2002010449A2 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
02/07/2002 | WO2002010444A1 A method of detecting microorganisms |
02/07/2002 | WO2002010443A1 Combinatorial probes and uses therefor |
02/07/2002 | WO2002010435A1 Methods of screening novel agents for use in cancer therapy and prevention |
02/07/2002 | WO2002010433A2 Method and device for detecting bacterial contamination |
02/07/2002 | WO2002010425A2 Ascorbic acid production from yeasts |
02/07/2002 | WO2002010420A2 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
02/07/2002 | WO2002010418A2 Targeting through integrins |
02/07/2002 | WO2002010417A2 Methods and compositions for the construction and use of viral envelops as display particles |
02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
02/07/2002 | WO2002010415A2 Methods for the controlled, automatic excision of heterologous dna from transgenic plants and dna-excising gene cassettes for use therein |
02/07/2002 | WO2002010414A2 Expression of biologically active polypeptides in duckweed |
02/07/2002 | WO2002010413A1 Isolation and characterization of a fiber-specific actin promoter from cotton |
02/07/2002 | WO2002010412A2 Novel regulatory genes involved in condensed tannin synthesis in plants |
02/07/2002 | WO2002010411A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
02/07/2002 | WO2002010410A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
02/07/2002 | WO2002010409A1 Antisense inhibition of her-3 expression |
02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
02/07/2002 | WO2002010407A1 Bioproduction of para-hydroxycinnamic acid |
02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
02/07/2002 | WO2002010405A2 A human disintegrin protein |
02/07/2002 | WO2002010404A2 Regulation of human masp-like serine protease |
02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
02/07/2002 | WO2002010401A2 18431 and 32374, human protein kinase family members and uses therefor |
02/07/2002 | WO2002010400A1 A NOVEL POLYPEPTIDE- tRNA GUANINE GLYCOSYLETRANSFERASE 17.82 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
02/07/2002 | WO2002010399A1 Novel carbonyl reductase, gene thereof and method of using the same |
02/07/2002 | WO2002010398A2 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms |
02/07/2002 | WO2002010396A1 Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
02/07/2002 | WO2002010395A1 Isoforms of an oxodicarboxylates transporter of s. cerevisiae |
02/07/2002 | WO2002010394A2 Nucleic acids, by means of which plants with altered metabolite content can be produced |
02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
02/07/2002 | WO2002010391A2 18610, a human transient receptor and uses thereof |
02/07/2002 | WO2002010390A2 57250, a human sugar transporter family member and uses thereof |
02/07/2002 | WO2002010389A2 Human ion channel proteins and polynucleotides encoding the same |
02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
02/07/2002 | WO2002010387A2 G-protein coupled receptors |
02/07/2002 | WO2002010386A2 Human vomeronasal receptor |
02/07/2002 | WO2002010385A1 A platelet aggregation inhibitor derived from snake venom and process for preparing the same |
02/07/2002 | WO2002010384A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
02/07/2002 | WO2002010383A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
02/07/2002 | WO2002010381A1 Novel protein inhibitor of apoptosis proteins |
02/07/2002 | WO2002010380A1 A novel polypeptide, a kruppel-like zinc finger protein zk110.12 and the polynucleotide encoding the polypeptide |
02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
02/07/2002 | WO2002010378A2 Antisense modulation of ptp1b expression |
02/07/2002 | WO2002010377A1 ISOLATION AND CHARACTERIZATION OF A FIBER-SPECIFIC β-TUBULIN PROMOTER FROM COTTON |
02/07/2002 | WO2002010376A1 HUMAN II TYPE 5α-REDUCTASE PROMOTER GENE AND USE THEREOF |
02/07/2002 | WO2002010375A1 Human source gene leading sequence, gene vector and gene expression strategy |
02/07/2002 | WO2002010374A2 Gene silencing using mrna-cdna hybrids |
02/07/2002 | WO2002010373A2 Apparatus and method for specific release of captured extension products |
02/07/2002 | WO2002010372A1 Method of producing functional protein domains |
02/07/2002 | WO2002010367A1 Chimeric receptors and their uses |
02/07/2002 | WO2002010365A2 Down-regulation of single genes and simultaneous down-regulation of multiple genes by nuclear localization of rna transcripts |
02/07/2002 | WO2002010364A2 Methods for enhancing targeted gene alteration using oligonucleotides |
02/07/2002 | WO2002010363A2 Protein phosphatases |
02/07/2002 | WO2002010362A2 Methods of controlling gene expression and gene silencing |
02/07/2002 | WO2002010360A1 Novel dna synthase |
02/07/2002 | WO2002010359A1 A method of diagnosis abnormalities by screening for tyrosine kinase like molecules or their signalling mediators |
02/07/2002 | WO2002010358A2 Nucleotide incorporating enzymes |
02/07/2002 | WO2002010357A2 Gsk3 polypeptides |
02/07/2002 | WO2002010355A2 Alpha-amylase mutants with altered stability |
02/07/2002 | WO2002010352A2 Production of human monoclonal antibodies |
02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
02/07/2002 | WO2002010346A2 Insulin producing cell-line obtained by electrofusion |
02/07/2002 | WO2002010344A2 Synchronised arabidopsis cell suspensions and uses thereof |
02/07/2002 | WO2002010341A1 Microsporidia isolate |
02/07/2002 | WO2002010340A1 $i(neospora caninum) isolate |
02/07/2002 | WO2002010339A2 Gene expression profile for kshv infection and methods for treating same |
02/07/2002 | WO2002010337A2 Method of cloning porcine animals |
02/07/2002 | WO2002010335A2 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
02/07/2002 | WO2002010334A2 Dna element promoter of transcription activity, active in human cells and general method for adjusting the activity thereof |
02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
02/07/2002 | WO2002010213A1 A novel polypeptide human mitochondrial translational initiation factor 15.4 and a polynucleotide encoding the same |
02/07/2002 | WO2002010211A1 A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it |
02/07/2002 | WO2002010210A2 Polypeptides for identifying herbicidally active compounds |
02/07/2002 | WO2002010207A2 Proton-translocating retinal protein |
02/07/2002 | WO2002010204A2 G protein-coupled receptors |
02/07/2002 | WO2002010203A2 Daz genes |
02/07/2002 | WO2002010202A2 G-protein coupled receptors and nucleic acids encoding same |
02/07/2002 | WO2002010201A2 Peptide-mediated delivery of molecules into cells |
02/07/2002 | WO2002010200A2 Pas domain proteins |
02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
02/07/2002 | WO2002010197A1 Cationic amphipathic peptides and the application thereof in gene transfer vectors |
02/07/2002 | WO2002010196A2 Identification of a novel glutamine transporter |